Contact Us

HOTEL NEWS

SunCar Technology Group Announces Share Repurchase Program

Feb 10, 2025

NEW YORK,Feb. 7,2025-- SunCar Technology Group Inc. ("SunCar" or the "Company") (Nasdaq: SDA),an innovative leader in cloud-based B2B auto services and auto e-insurance in China,to

'The convergence between of AI and the Biology' LG Creates "Next-Generation Protein Structure Prediction AI" for Drug Discovery

Feb 10, 2025

SEOUL,South Korea,Feb. 7,2025-- On the 5th,LG AI Research signed a joint research agreement at the Global Lounge of LG Science Park in Magok,Gangseo-gu,Seoul,with Prof. Min-Kyung Baek from the school

CARsgen's First Enrolled Subject in the THANK-u Plus™ Platform-Based Allogeneic CAR-T Trial Achieves sCR at Week 4

Feb 10, 2025

SHANGHAI,Feb. 10,2025-- CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK),a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignancies and solid tumors

Billion Electric Group Delivers 100% Green Energy to Pacific Islands with Smart Solar-Storage Microgrids

Feb 10, 2025

KOROR,Palau,Feb. 9,2025--Billion Electric Group (TWSE: 3027),in collaboration with Taiwanese partners,has successfully deployed 495 kWp of solar PV and 1,997 kWh of battery energy storage systems (BES

Actinogen announces new and unique nonproprietary name of 'emestedastat' for Xanamem

Feb 7, 2025

Late-stage Alzheimer\'s trial opens 10 new sites in USA,with results due in 2025 and 2026 SYDNEY,Feb. 5,2025-- Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO)

Serplulimab Approved in the EU for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Feb 7, 2025

Serplulimab is the world\'s first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC

1 ... 92 93 94 95 96 97 98 ... 340